Evidence map›Paper›PMID 24398669›Full record

ArticleCarcinogenesis2014

Molecular basis of aflatoxin-induced mutagenesis-role of the aflatoxin B1-formamidopyrimidine adduct.

Ying-Chih Lin, Liang Li, Alena V Makarova, Peter M Burgers, Michael P Stone, R Stephen Lloyd

Open access · bronzeAbstract read
In one paragraph

Article in Carcinogenesis, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
6.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 72 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. The aflatoxin BNAR cancer · 2025
    Article
  7. Review
  8. Aflatoxin BEnvironmental and molecular mutagenesis · 2025
    Article
  9. Article
  10. Aflatoxin BEnvironmental toxicology and pharmacology · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. The aflatoxin BEnvironmental and molecular mutagenesis · 2024
    Article
  16. Frequencies and spectra of aflatoxin BNAR molecular medicine · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ying-Chih LinOregon Institute of Occupational Health Sciences and Cancer Biology Program, Oregon Health & Science University, Portland, OR 97239, USA.
Liang LiDepartment of Chemistry, Vanderbilt University, Nashville, TN 37235, USA.
Alena V MakarovaDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO 63110, USA and.
Peter M BurgersDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO 63110, USA and.
Michael P StoneDepartment of Chemistry, Vanderbilt University, Nashville, TN 37235, USA.
R Stephen LloydOregon Institute of Occupational Health Sciences and Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR 97239, USA lloydst@ohsu.edu.
Oregon Health & Science University · USVanderbilt University · USWashington University in St. Louis · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Structural Biology Facility CoreP30ES000267 · NIEHS · VANDERBILT UNIVERSITY · PI GUENGERICH, F PETER · 1985 to 2014
$20.3M
TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGYT32ES007028 · NIEHS · VANDERBILT UNIVERSITY · PI F PETER Guengerich, Fiona Edith Harrison · 1985 to 2026
$15.7M
Synthetic Approaches to Carcinogen-Linked OligonucleotidesP01CA160032 · NCI · VANDERBILT UNIVERSITY · PI STONE, MICHAEL P · 2012 to 2022
$14.0M
ENZYMOLOGY OF REPLICATION OF YEAST CHROMOSOMAL DNAR01GM032431 · NIGMS · WASHINGTON UNIVERSITY · PI BURGERS, PETER M · 1985 to 2015
$6.5M
DNA Adduct-Induced MutagenesisR01CA055678 · NCI · VANDERBILT UNIVERSITY · PI STONE, MICHAEL P · 1992 to 2016
$4.0M
Program in Molecular and Cellular BiosciencesT32GM071338 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI MASLEN, CHERYL L · 2005 to 2020
$3.5M
NCI NIH HHS P01 CA160032NCI NIH HHS P30 CA068485NCI NIH HHS R01 CA055678NIEHS NIH HHS P30 ES000267NIEHS NIH HHS P30 ES00267NIEHS NIH HHS T32 ES007028NIGMS NIH HHS GM 032431NIGMS NIH HHS R01 GM032431NIGMS NIH HHS T32 GM071338
6 · The paper itself

Abstract

Aflatoxin B1 (AFB1) is a known carcinogen associated with early-onset hepatocellular carcinoma (HCC) and is thought to contribute to over half a million new HCCs per year. Although some of the fundamental risk factors are established, the molecular basis of AFB1-induced mutagenesis in primate cells has not been rigorously investigated. To gain insights into genome instability that is produced as a result of replicating DNAs containing AFB1 adducts, site-specific mutagenesis assays were used to establish the mutagenic potential of the persistent ring-opened AFB1 adduct, AFB1-formamidopyrimidine (AFB1-FAPY). This lesion was highly mutagenic, yielding replication error frequencies of 97%, with the predominant base substitution being a G to T transversion. This transversion is consistent with previous mutational data derived from aflatoxin-associated HCCs. In vitro translesion synthesis assays demonstrated that polymerase (pol) ζ was the most likely candidate polymerase that is responsible for the G to T mutations induced by this adduct.

Indexed as

Aflatoxin B1AnimalsCarcinoma, HepatocellularChlorocebus aethiopsCOS CellsDNA AdductsDNA ReplicationDNA, Single-StrandedHumansLiver NeoplasmsMutagenesis, Site-DirectedMutationPolymerase Chain ReactionPyrimidinesAflatoxin B1aflatoxin B1-formamidopyrimidineDNA AdductsDNA, Single-StrandedPyrimidines

Identifiers

PMID24398669
PMCPMC4076807
OpenAlexW2101364159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.